Ruiz-Villaverde, R.; Vasquez-Chinchay, F.; Rodriguez-Fernandez-Freire, L.; C. Armario-Hita, J.; Pérez-Gil, A.; Galán-Gutiérrez, M.
Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives. Life 2022, 12, 1412.
https://doi.org/10.3390/life12091412
AMA Style
Ruiz-Villaverde R, Vasquez-Chinchay F, Rodriguez-Fernandez-Freire L, C. Armario-Hita J, Pérez-Gil A, Galán-Gutiérrez M.
Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives. Life. 2022; 12(9):1412.
https://doi.org/10.3390/life12091412
Chicago/Turabian Style
Ruiz-Villaverde, Ricardo, Fiorella Vasquez-Chinchay, Lourdes Rodriguez-Fernandez-Freire, Jose C. Armario-Hita, Amalia Pérez-Gil, and Manuel Galán-Gutiérrez.
2022. "Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives" Life 12, no. 9: 1412.
https://doi.org/10.3390/life12091412
APA Style
Ruiz-Villaverde, R., Vasquez-Chinchay, F., Rodriguez-Fernandez-Freire, L., C. Armario-Hita, J., Pérez-Gil, A., & Galán-Gutiérrez, M.
(2022). Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives. Life, 12(9), 1412.
https://doi.org/10.3390/life12091412